Introduction
Schwann cells are the myelin-forming cells in the peripheral nervous system (PNS) and are responsible for the formation and maintenance of the myelin sheath around axons in the peripheral nerve fibers. Schwann cells are known to secrete a variety of cell adhesion molecules [1] , neurotrophic factors [2] , and cytokines [3, 4] that play important roles in axonal growth, and regeneration.
Earlier studies have indicated that proinflammatory cytokines produced by the Schwann cells play focal roles in causing damage to myelin or axons in diseases of the PNS particularly in inflammatory demyelinating neuropathies [5] . Although the macrophages and their products are the primary effectors in demyelination and axonal degeneration [6] , cytokines such as IL-1b, IL-6 or tissue necrosis factor-a (TNF-a) released from Schwann cells also contribute to the progression of the disease process in a paracrine manner [6] .
Earlier studies on Schwann cells examined biopsy samples of human tissues or Schwann cell preparations of rodents [7, 8] , and only few studies have tested primary cultures of human Schwann cells [3] . It is vital to establish in-vitro assay system for cytokines and cytokine receptors in human Schwann cells, so that we can understand the cause and progression of PNS diseases such as inflammatory demyelinating neuropathies. In this study, human Schwann cells have been isolated, propagated in culture, and these cells were used to determine the expression levels of cytokines and cytokine receptors at the basal condition and following treatment with inflammatory cytokines.
Materials and methods

Reagents
The following reagents were purchased from R&D systems (Minneapolis, Minnesota, USA): recombinant human IL-1b, IL-6, IFN-g, TNF-a and TGF-b, and enzyme-linked immunosorbent assay (ELISA) kits for IL-6 and IL-8.
Primary human Schwann cell culture Dorsal root ganglia (DRG) were isolated from four human fetuses, legally and therapeutically aborted, of 15-18 weeks gestation, and dissociated cell cultures of DRG were established as previously described [9] . In brief, the ganglia were incubated in Dulbecco's modified Eagle's medium (DMEM) containing 0.25% collagenase (Worthington, Lakewood, New Jersey, USA) and 40 mg/ml DNase for 60 min at 371C, dissociated into single cells by gentle pipetting with a siliconized Pasteur pipette, washed twice with DMEM, and finally suspended in feeding medium consisting of DMEM supplemented with 5% horse serum, 5 mg/ml glucose, 20 mg/ml gentamicin and 2.5 mg/ml amphotericin B, and plated in 60-mm plastic dishes coated with poly-L-lysine. Twenty-four hours later, most of fibroblasts were found to attach to the plastic dish surface. Floating cells consisted of neurons and Schwann cells were replated in new poly-L-lysine or matrigel-coated 60-mm plastic dishes. Forty-eight hours later, culture medium was replaced with fresh medium containing 5 Â 10 À5 M each of 5-fluoro-2 0 -deoxyuridine (FUdR; Sigma, St Louis, Missouri, USA) and uridine (Sigma) for 48 h to eliminate fast-growing fibroblasts. FUdR treatment was repeated a week later. When cultures were enriched with Schwann cells, then feeding medium was supplemented with 10-ng/ml neuregulin b1, a specific Schwann cell growth factor every 3 days for 2-3 weeks. Our earlier study has indicated that treatment with neuregulin b1 induces a 10-fold increase in cell number of human Schwann cells over 72-h time period [10] . About 30 ml of cell suspension (2 Â 10 4 cells) were also seeded onto poly-L-lysine-coated round (9-mm diameter) Aclar plastic (Honeywell, Chicago, Illinois, USA) coverslips that were housed in 60-mm plastic dishes. Twenty-four hours later, each dish was flooded with feeding medium. For comparison, we also used a stable cloned cell line of human Schwann cell (K10), which we have previously generated via infection with a retroviral vector encoding v-myc. The expression of cytokines IL-1bBIL-15 (except IL-14), TNF-a and transforming growth factor-b, and cytokine receptors for IL-1b B IL-15 (except IL-14), TNF-a and gp130 was examined by RT-PCR in primary human Schwann cells. Total RNA was extracted from human Schwann cell cultures using TRIzol reagent (Gibco-BRL, Gaithersburg, Maryland, USA). Complimentary DNA (cDNA) templates from each sample were prepared from 2 mg of total RNA primed with oligo dT primers (Pharmacia, Gaithersburg, Maryland, USA) using 400 units of moloney murine leukemia virus (MMLV) reverse transcriptase (Gibco-BRL) followed by 25 PCR amplification cycles (941C for 30 s, annealing at 601C for 60 s and extension at 721C for 90 s). Glyceraldehyde-3-phosphate dehydrogenase was used as a reaction standard. About 10 ml of each PCR product was analyzed by 1.5% agarose gel electrophoresis.
Enzyme-linked immunosorbent assay analysis
Production of IL-6 and IL-8 in human Schwann cells was determined in culture supernatants using specific ELISA kits (R&D Systems) with a sensitivity to detect IL-6 at 0.7 pg/ml and IL-8 at 10 pg/ml. Human Schwann cells grown in 6-well plates (2 Â 10 6 cells/well) were treated with 10 ng/ml of IL-1b or IFN-g for 48 h. At the end of each experiment, culture supernatants were collected, centrifuged and stored at À701C.
Results
Primary human Schwann cell culture After exclusion of NGF from the culture medium of DRG cell cultures and successive treatment with FUdR and uridine, cultures were mostly made up with spindle-shaped cells, the morphology of which is characteristic of Schwann cells (Fig. 1a) . The purity of Schwann cells in the culture was over 98% as determined by immunochemical staining of S-100 protein, an antigen specific for Schwann cells.
Reverse transcribed-PCR analysis for cytokines and cytokine receptors The expression of mRNAs for cytokines and cytokine receptors was determined by RT-PCR in human Schwann cells under nonstimulated condition (Fig. 1b) . The results demonstrated that normal human Schwann cells constitutively express detectable quantities of mRNA transcripts of IL-1b, IL-6, IL-8, IL-11, IL-12, IL-15 and TGF-b under nonstimulated conditions (Fig. 1b) . Human Schwann cells also expressed mRNA transcripts for IL-1RI, IL-4R, IL-6R, IL-8R, IL-13R, TNFR-I, TNFR-II and gp130 (Fig. 1c) .
Upregulation of mRNA for cytokines
To determine the effects of various cytokines on cytokine expression, the Schwann cell cultures were treated with IL-1b, IL-6, IFN-g, TNF-a or TGF-b (Fig. 2) .
Expression of IL-1b was upregulated following treatment with IL-1b or TGF-b. IL-6 expression was upregulated after treatment with IL-1b, IFN-g, TNF-a or TGF-b. IL-15 was induced by IL-1b, IFN-g or TGF-b. IL-12 expression was downregulated following treatment with IL-6, IFN-g or TGF-b, whereas expression of IL-8 and TGF-b remained unchanged by any of the cytokines listed above. It is also noteworthy that the level of P0 mRNA transcripts increased with TGF-b treatment.
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Enzyme-linked immunosorbent assays of cytokines Protein production of selected cytokines, IL-6 and IL-8, was determined in cultures of human Schwann cells following treatment with IL-1b or IFN-g using ELISAs (Fig. 3) . Treatment of Schwann cells with IL-1b induced a significantly increased release of IL-6, whereas IFN-g reduced IL-6 production significantly (Fig. 3) . IFN-g treatment reduced IL-8 levels but there was no change in IL-8 production after IL-1b treatment (Fig. 3) .
To confirm that these changes were not caused by potentially contaminating cells in primary human Schwann cells, we also used a stable cloned cell line of human Schwann cell (K10) for comparison. K10 exhibited mRNA of S-100b, P0, GFAP (Fig. 4a) . After treatment with either IL-1b (10 ng/ml) or IFN-g (10 ng/ml) for 48 h, ELISA showed an increase of IL-6 in IL-1b-treated samples and its decrease in IFN-g-treated samples (Fig. 4b) .
Discussion
In this study, we have investigated the expression of cytokines and cytokine receptors in enriched population of human Schwann cells cultured from fetal human DRG. During the early phase of human fetal DRG cell culture, three-step process of Schwann cell enrichment was undertaken. First, replate neurons and Schwann cells to new dishes whereas majority of fibroblasts were left attached to old dishes; second, by treatment with the antimitotic agent FUdR and then finally, treatment with a specific growth factor neuregulin b.
Earlier studies have indicated that initiation and progression of demyelination and axonal degeneration in the PNS diseases may be immune-mediated [11, 12] . The present results that the cultured human Schwann cells express transcripts for cytokines such as of IL-1b, IL-6, IL-8, IL-11, IL-12, IL-15 and TGF-b indicate that human Schwann cells are capable of producing these cytokines following inflammatory reaction or damage to the PNS and may exacerbate the processes of regeneration or degeneration in the nerve injury.
An earlier study has indicated that the proinflammatory cytokines released from the human Schwann cells play roles in leukocyte recruitment during the nerve injury [3] . IL-1b mediates adherence of circulating neutrophils or monocytes on endothelial cells by inducing the expression of specific adhesion molecules in the lesion sites [3] . Increased expression of both IL-6 and IL-15 was also found in human Schwann cell cultures treated with IL-1b. IL-6, which is a pleiotropic cytokine, might work synergistically with IL-1b. Upregulated IL-15 may influence the microenvironment around Schwann cells by activating innate immune cells including natural killer cells [13] .
As the expression of TNF-a was not altered in human Schwann cells even after stimulations with several proinflammatory cytokines including IL-1b, IL-6, IFN-g, TNF-a or TGF-b, it appears that the upregulation of TNF-a in the damaged PNS lesions is likely to occur in other cell types, such as infiltrating macrophages. It is interesting to note that the treatment with IFN-g, a pleiotropic cytokine with antiviral and immunoregulatory activities, increased the mRNA expression of IL-15 in human Schwann cells, whereas it reduced the expression of IL-6 and IL-12. ELISA analysis confirmed that IFN-g decrease the secretion of IL-6 and IL-8, which are proinflammatory cytokine and chemokine. Treatment with IL-1b, IFN-g or TGF-b induced expression of IL-15, which may keep the inflammation active by protecting leukocytes from apoptosis [14, 15] . Our study suggests that complex interaction of several cytokines should be considered in the peripheral nerve injuries.
IFN-g reduced the protein production of IL-6 and IL-8 in human fetal Schwann cells, whereas the expression of these mRNAs was not changed. The MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide) assay for cell viability in human fetal Schwann cell cultures was performed, showing no changes of cellular viability (data not shown). For confirming the results of IL-6 expression with IL-1b and IFN-g in primary human Schwann cell cultures, we used K10 cells and obtained the same results. The dissociation between mRNA and protein production of IL-6 and IL-8 may be attributable to a potential three mechanisms; these mRNAs might be less stable; or less proficiently translated; or translocated to cytoplasmic compartments that hold mRNA in a transcriptionally repressed state [16] . In the 3 0 -untranslated region of IL-6 and IL-8, adenosine/uridine (AU)-rich sequences have been identified. These AU-rich sequences in IL-6 and IL-8 are implied to accelerate degradation of the mRNA [17, 18] , and may be related to ineffective translation. Disturbed translation was observed exclusively with IFN-g stimulation in this study, and may be caused by posttranscriptional regulation of the IL-6 and IL-8 mRNA. In support for this hypothesis, posttranscriptional downregulation has been similarly shown for thrombomodulin mRNA through AU-rich sequences in its 3 0 -untranslated region after IFN-g stimulation [19] .
It is also noteworthy that the treatment of human Schwann cells with TGF-b showed the most prominent increase of mRNA transcripts for IL-1b, IL-6 and IL-15. As TGF-b is known to exert a negative effect on differentiation of Schwann cells and also act toxic to Schwann cells synergistically with TNF-a [20] , TGF-b could be one of key factors that influence Schwann cell response in the peripheral injuries.
This study examined the expression of cytokine and cytokine receptors in enriched population of human Schwann cells grown in culture thoroughly for the first time in the literature. The present results suggest that human Schwann cells respond to cytokines released by the local or infiltrating cell types in the nerve injury sites and modify the pathology of disease by secreting pleiotropic cytokines that regulate inflammation, cell death or immune responses. The secreted inflammatory cytokines may play a role in leukocyte recruitment and also exacerbation of axonal injury process. The results of this study should serve for the understanding of the pathophysiology of axonal injury and the process of regeneration.
